Division of Epidemiology, Norwegian Institute of Public Health, Nydalen, Oslo, Norway.
J Clin Epidemiol. 2011 Aug;64(8):878-84. doi: 10.1016/j.jclinepi.2010.10.014. Epub 2011 Jan 13.
To examine the validity of (1) maternal questionnaire report of children's use of antiasthmatics using a prescription database as the reference standard and (2) dispensed antiasthmatics as a measure of asthma using maternal report of children's asthma as the reference standard.
A total of 3,394 children in the Norwegian Mother and Child Cohort Study aged 7 years were linked to the Norwegian Prescription Database. Maternal report of both children's use of antiasthmatics during the preceding year and the presence of asthma was compared with data on dispensed antiasthmatics.
A total of 2,056 mothers responded and reported use of antiasthmatics during the previous year in 125 of 147 children who had been dispensed antiasthmatics (sensitivity 85.0%). Of the 1,909 children with no dispensed antiasthmatics, 1,848 had no maternal report of antiasthmatic use (specificity 96.8%). Mothers reported current asthma in 133 (6.5% of 2,056) children, including in 122 (5.9%) reported as verified by a doctor. Of these 122, 98 had been dispensed antiasthmatics during the preceding year (sensitivity 80.3%). Only 1.2% of the children without reported asthma were dispensed antiasthmatics.
Mother-reported use of antiasthmatics during the previous year among 7-year-old children is highly valid. Dispensed antiasthmatics would be a useful proxy for the presence of current asthma when disease data are not available.
检验(1)使用处方数据库作为参考标准,母亲通过问卷报告儿童使用抗哮喘药物的情况的有效性,以及(2)以儿童哮喘的母亲报告为参考标准,将配给的抗哮喘药物作为哮喘的衡量标准的有效性。
共有 3394 名 7 岁的挪威母婴队列研究的儿童与挪威处方数据库相关联。将母亲报告的儿童在过去一年中使用抗哮喘药物的情况以及哮喘的存在情况与配给的抗哮喘药物的数据进行比较。
共有 2056 名母亲做出回应,报告了 147 名儿童中 125 名儿童在过去一年中使用了抗哮喘药物(敏感性 85.0%)。在 1909 名未配给抗哮喘药物的儿童中,1848 名儿童的母亲报告没有使用抗哮喘药物(特异性 96.8%)。133 名(2056 名儿童的 6.5%)儿童的母亲报告了当前哮喘,其中 122 名(经医生证实)为确诊哮喘。在这 122 名儿童中,有 98 名在过去一年中配给了抗哮喘药物(敏感性 80.3%)。没有报告哮喘的儿童中,只有 1.2%配给了抗哮喘药物。
7 岁儿童在过去一年中母亲报告使用抗哮喘药物的情况具有高度的有效性。当无法获得疾病数据时,配给的抗哮喘药物可以作为当前哮喘存在的有用替代指标。